Botox prevents migraines by blocking pain-signaling chemicals before they can trigger an attack. It’s injected into specific muscles around the head and neck every 12 weeks, and it’s FDA-approved for adults with chronic migraine, defined as 15 or more headache days per month. The treatment doesn’t work like a painkiller that stops a migraine in progress. Instead, it interrupts the chain reaction that causes migraines to start in the first place.
How Botox Interrupts Migraine Pain Signals
Migraines involve a major nerve network called the trigeminal nerve, which runs through your face, head, and jaw. When a migraine begins, nerve fibers near the surface of the brain become overactive and release a flood of inflammatory chemicals. These chemicals cause blood vessels to dilate and surrounding tissue to swell, which creates the throbbing, intense pain characteristic of a migraine.
Botox works by blocking the release of these pain-signaling chemicals at the nerve endings. The most important one is CGRP, a protein that powerfully dilates blood vessels and amplifies pain during a migraine attack. Botox also suppresses other inflammatory signals, including nitric oxide and substance P. By cutting off these chemical messengers at their source, Botox essentially quiets the nerve endings so they’re less likely to fire off and trigger an attack. Think of it as turning down the volume on an overly sensitive alarm system.
Who Qualifies for Treatment
Botox is specifically approved for chronic migraine, not occasional or episodic migraine. The FDA defines chronic migraine as headaches occurring on 15 or more days per month, with each headache lasting at least four hours. If you have 14 or fewer headache days per month, Botox hasn’t been shown to be effective and isn’t approved for your situation.
You also need to be 18 or older. Most insurance plans require prior authorization before covering Botox for migraine, and many will want documentation that you’ve tried and failed other preventive treatments first.
What the Injection Process Looks Like
Each treatment session involves 31 small injections totaling 155 units of Botox, spread across seven muscle groups in your head and neck. The injections target your forehead, the muscles between your eyebrows, your temples, the back of your head, your neck, and your upper shoulders. Each injection delivers just 5 units in a tiny volume of fluid through a very fine needle.
The whole process takes about 15 to 20 minutes. Most people describe the sensation as a series of quick pinches rather than sharp pain. You can return to normal activities the same day, though your provider may recommend avoiding rubbing the injection sites or lying flat for a few hours.
How Quickly It Works
Botox for migraine is not an immediate fix. The effects build gradually over multiple treatment cycles, with sessions scheduled every 12 weeks. Many people don’t notice significant improvement until after their second or third round of injections, which means it can take six to nine months to fully gauge whether the treatment is working for you.
In the landmark clinical trials (known as the PREEMPT studies), patients receiving Botox experienced an average reduction of 8.5 headache days per month by week 24. Nearly half of treated patients, 47.1%, achieved at least a 50% reduction in their monthly headache frequency, which is considered a clinically meaningful response.
Long-Term Results Over Years of Use
The longer-term picture is even more encouraging. A real-world study following 579 chronic migraine patients for up to 11 years found dramatic, sustained improvement. Patients started with an average of 22.7 headache days per month. After five years of consistent treatment, that number dropped to 5.5 days per month.
The reduction in pain medication use was just as striking. Patients went from taking an average of 33.4 doses of acute medication per month down to 5.7 doses at the five-year mark. Among all patients in the study, about 60% achieved a greater than 75% reduction in headache days, and another 31% saw a 50% to 75% reduction. Only about 5% of patients were true non-responders.
Disability scores told a similar story. Of the patients tracked through five years, none remained in the severe disability category, and 62% had improved to minimal disability. For people whose lives have been significantly limited by chronic migraine, that kind of shift is substantial.
Side Effects and Safety
The most common side effect is neck pain, which occurred in the majority of reported adverse events. Other reactions that showed up in at least 3% of patients in clinical trials included upper respiratory infections, dizziness, and musculoskeletal pain. A small number of patients (about 12.5% of those who had any side effect) experienced drooping of the eyelid, known as ptosis, which resolved on its own.
One reassuring finding from long-term data: the rate of side effects actually decreases over time. In the 11-year study, the overall incidence was just 3.0 adverse events per 100 person-years of treatment, and no new adverse events were reported beyond the 36-month mark. This suggests that if you tolerate the first several rounds well, you’re unlikely to develop new problems later.
In rare cases, the effects of Botox can spread beyond the injection site, causing temporary weakness in nearby muscles. One documented case involved a teenager who lost the ability to raise her eyebrows two days after treatment; the issue resolved completely within 49 days.
What to Expect Over Your First Year
If you’re starting Botox for chronic migraine, a realistic timeline looks something like this. Your first session places 31 injections across your head and neck. Over the next few weeks, you may notice a gradual decrease in headache intensity or frequency, or you may not notice much change at all. At the 12-week mark, you return for your second round. Many patients begin to see clearer benefits after this second cycle.
By the third treatment, around the nine-month point, you and your provider can make a more informed judgment about whether Botox is working. Some insurance plans require documentation of response at this stage to continue covering the treatment. The patients who respond well typically continue on a regular 12-week schedule, with some providers adjusting the dose slightly (up to 195 units across up to 39 sites) based on where your pain is concentrated.
Because the effects wear off gradually before your next appointment, some people notice their headaches creeping back in the last week or two before their next session. This is normal and doesn’t mean the treatment is failing.